Literature DB >> 10484962

Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression.

F Benedetti1, A Serretti, C Colombo, E Campori, B Barbini, D di Bella, E Smeraldi.   

Abstract

OBJECTIVE: A functional polymorphism in the transcriptional control region upstream of the coding sequence of the 5-hydroxytryptamine transporter (5-HTT) has been reported. This polymorphism has been shown to influence the antidepressant response to fluvoxamine and paroxetine. The authors tested the hypothesis that the allelic variation of the 5-HTT-linked polymorphic region (5-HTTLPR) could influence the response of depressed patients to total sleep deprivation.
METHOD: Sixty-eight drug-free inpatients with bipolar depression underwent a night of total sleep deprivation. 5-HTTLPR was genotyped in these patients. Changes in perceived mood were rated on a visual analogue scale and analyzed by using repeated measures analysis of covariance.
RESULTS: Patients who were homozygotic for the long variant of 5-HTTLPR showed a significantly better mood amelioration after total sleep deprivation than those who were heterozygotic and homozygotic for the short variant.
CONCLUSIONS: The influence of 5-HTTLPR on response to total sleep deprivation is similar to its observed influence on response to serotonergic drug treatments. This finding supports the hypothesis of a major role for serotonin in the mechanism of action of total sleep deprivation in depression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484962     DOI: 10.1176/ajp.156.9.1450

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

Review 1.  Role of pharmacogenomics in individualising treatment with SSRIs.

Authors:  Dalu Mancama; Robert W Kerwin
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.

Authors:  Albert Putzhammer; Anja Schoeler; Thomas Rohrmeier; Philipp Sand; Goeran Hajak; Peter Eichhammer
Journal:  Psychopharmacology (Berl)       Date:  2004-08-18       Impact factor: 4.530

3.  A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment.

Authors:  Amira Pierucci-Lagha; Jonathan Covault; Herbert L Bonkovsky; Richard Feinn; Christine Abreu; Richard K Sterling; Robert J Fontana; Henry R Kranzler
Journal:  Psychosomatics       Date:  2010 Mar-Apr       Impact factor: 2.386

Review 4.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

5.  Sleep duration and depressive symptoms: a gene-environment interaction.

Authors:  Nathaniel F Watson; Kathryn Paige Harden; Dedra Buchwald; Michael V Vitiello; Allan I Pack; Eric Strachan; Jack Goldberg
Journal:  Sleep       Date:  2014-02-01       Impact factor: 5.849

Review 6.  Basic sleep and circadian science as building blocks for behavioral interventions: a translational approach for mood disorders.

Authors:  Lauren D Asarnow; Adriane M Soehner; Allison G Harvey
Journal:  Behav Neurosci       Date:  2014-04-28       Impact factor: 1.912

7.  Genetic bases of comorbidity between mood disorders and migraine: possible role of serotonin transporter gene.

Authors:  Elena Marino; Bongiorno Fanny; Cristina Lorenzi; Adele Pirovano; Linda Franchini; Cristina Colombo; Placido Bramanti; Enrico Smeraldi
Journal:  Neurol Sci       Date:  2009-11-21       Impact factor: 3.307

8.  Hypersomnia in Mood Disorders: a Rapidly Changing Landscape.

Authors:  David T Plante
Journal:  Curr Sleep Med Rep       Date:  2015-06

Review 9.  Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges.

Authors:  Ruth Benca; Marilyn J Duncan; Ellen Frank; Colleen McClung; Randy J Nelson; Aleksandra Vicentic
Journal:  Brain Res Rev       Date:  2009-09-18

10.  Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study.

Authors:  Mushtaq A Margoob; Dhuha Mushtaq; Imtiyaz Murtza; Huda Mushtaq; Arif Ali
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.